1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025 is sponsored by Cancer Australia. Cancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025 is a grant from Cancer Australia, co-funded with the National Health and Medical Research Council (NHMRC), that funds research on early-onset cancers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# Cancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025 | NHMRC * Health adviceOpen submenu * Research policyOpen submenu * Manage your fundingOpen submenu * NHMRC grant programOpen submenu * Medical Research Future Fund * International collaborative fundingOpen submenu * Targeted Calls for Research * Outcomes and data on researchOpen submenu * Working together to support research Close submenuManage your funding * NHMRC FundingOpen submenu * MRFF FundingOpen submenu Close submenuNHMRC Funding * Funding agreement and deed of agreement * Administering InstitutionsOpen submenu * Direct Research Cost Guidelines * Personnel and Salary Support PackagesOpen submenu Close submenuAdministering Institutions * Institutional Annual Compliance Report * Progress, final and additional reporting Close submenuPersonnel and Salary Support Packages * Previous Personnel Support Package rates * Previous Salary Support Package rates Close submenuMRFF Funding * MRFF Eligible OrganisationsOpen submenu * Reporting and milestonesOpen submenu * Direct Research Costs and Personnel and Salary Support Packages Close submenuMRFF Eligible Organisations * Institutional approvals and grant conditions Close submenuReporting and milestones * Scientific reporting and milestones Close submenuNHMRC grant program * NHMRC grant program schemes Close submenuInternational collaborative funding * International engagement strategy and activities * International collaborative health research funding * Other opportunities for international collaboration Close submenuOutcomes and data on research * Outcomes of funding rounds Close submenuHealth advice * Aboriginal and Torres Strait Islander health * Children’s health and development * Environmental healthOpen submenu * Public healthOpen submenu * Guidelines for Guidelines Close submenuEnvironmental health * Water quality and health Close submenuPublic health * Health effects of water fluoridation * Complementary medicines Close submenuResearch policy * Consumer and community involvementOpen submenu * Embryo research licensingOpen submenu * International engagement * Gender equityOpen submenu * Research prioritiesOpen submenu Close submenuConsumer and community involvement * Consumer and community engagement * Completed consultation activities * Consumer and community representative involvement in the peer review process * Review of the Statement on Consumer and Community Involvement Close submenuEmbryo research licensing * Commonwealth and State Legislation * Information for applicants * Information for Licence Holders * Embryo Research Licensing Committee reports to parliament * Import and export of cell lines * Database of Licences issued * Training and Quality Assurance * National Statement on Ethical Conduct in Human Research * Ethical guidelines for research with Aboriginal and Torres Strait Islander Peoples * Ethical guidelines for Assisted Reproductive Technology * Ethical guidelines for cell, tissue and organ donation and transplantation * Guide for assessing research involving AI * Human research ethics committees * National Certification Scheme * The Human Research Ethics Applications (HREA) * Ethical issues and further resources Close submenuGender equity * NHMRC Gender Equity Strategy * Structural priority funding and gender equity * Administering Institutions – consideration of gender equity * Statement on Sex and Gender in Research * Sex, gender, variations of sex characteristics and sexual orientation in the grant program Close submenuResearch priorities * Community research priorities portal * NHMRC health priorities 2024–2027 * Regional, Rural and Remote Health Equity * Framework for Identifying and Prioritising Targeted Calls for Research * Targeted Calls for Research Prioritisation Criteria Rubric * Guide for Proposing Targeted Calls for Research * Leadership and governanceOpen submenu * Publications and resourcesOpen submenu * NHMRC AwardsOpen submenu * Accountability and reporting Close submenuLeadership and governance * Legislative basis to NHMRC * Senior executive and leadership team Close submenuPublications and resources * Annual reports and corporate plans Close submenuNHMRC Awards * Research Excellence Awards * Temporary Employment Register * How we select our people * Indigenous internship program [](https://www.
nhmrc. gov.au/ "Home") * Outcomes of funding rounds [](https://www. nhmrc.
gov.au/funding/find-funding/cancer-australia-research-initiative-targeted-call-research-early-onset-cancer-2025#off-canvas "Menu") * Medical Research Future Fund * International collaborative funding * Targeted Calls for Research * Outcomes and data on research * Working together to support research Research funding statistics and data * Aboriginal and Torres Strait Islander health * Children’s health and development * Guidelines for Guidelines Guidelines for Guidelines * Consumer and community involvement * Embryo research licensing * International engagement Embryo research licensing * Leadership and governance * Publications and resources * Accountability and reporting 3.
Cancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025 # Cancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025 [](https://www. nhmrc.
gov.au/funding/find-funding/cancer-australia-research-initiative-targeted-call-research-early-onset-cancer-2025) Cancer Australia has established the new Cancer Australia Research Initiative (CARI), to reflect the contemporary cancer research landscape and ensure alignment with the Australian Cancer Plan to fund cancer research in areas of unmet and emerging need.
CARI is directed by Cancer Australia, jointly funded by Cancer Australia and NHMRC and designed in accordance with the NHMRC’s Targeted Calls for Research (TCR) model. The CARI will be delivered annually as a series of one-time grant opportunities, commencing in 2025-26.
Proposals will be asked to demonstrate translational potential and build capacity in the cancer research workforce, including through opportunities for early to mid-career researchers. CARI is a key mechanism for Cancer Australia to meet its legislated requirements, reflecting the current cancer research landscape, and ensuring alignment with the Australian Cancer Plan to fund cancer research in areas of unmet and emerging need.
Cancer Australia identified early-onset cancers as a strategic priority due to its global rise and diverse tumour sub-types, necessitating further research on environmental and genetic interactions.
The first CARI TCR grant opportunity aims to: * enhance understanding of early-onset cancer and develop novel clinical approaches for earlier diagnosis and innovative models of care to ensure effective management for those diagnosed with early-onset cancers.
* support programs that leverage existing, multidisciplinary, collaborative activities and that are designed to link to enduring and broad-based research infrastructure initiatives that will inform policy and large scale, novel research for early-onset cancer in the future.
This aim should be achieved with strategic, long-term approaches to address the possible causes, pathogenesis, early recognition and diagnosis as well as complexities of management and survivorship associated with early-onset cancers. Applications may focus on a single tumour sub-type or multiple tumour types. Proposals addressing cancers that have a greater burden of disease are encouraged.
Further information about the TCR, its objectives, outcomes, available funds and timeframes is available on GrantConnect. September 2025 – February 2026 ## Contact research admin office If you need more information, contact your Research Administration Office in the first instance.
If you need help and are unable to satisfy your concern through your Administering Institution (or MRFF Eligible Organisation), contact the Research Help Centre. Go to the National Health and Medical Research Council home page | Australian Government NHMRC acknowledges the Traditional Custodians of the lands around Australia and pays our respect to their Elders, both past and present.
**Your feedback matters** We're always looking for ways to improve our site. * Connect with the National Health and Medical Research Council on Facebook * Connect with the National Health and Medical Research Council on Twitter * Connect with the National Health and Medical Research Council on LinkedIn * Connect with the National Health and Medical Research Council on Instagram
According to the current listing, eligibility includes: NHMRC-approved administering institutions. Confirm the full requirements in the official notice before applying.
Cancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025 is funded by Cancer Australia. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article